Adverse Immune Effects of Nanomedicines and Biologicals– Under the Microscope
Janos Szebeni, Director of the Nanomedicine Research and Education Center, Bay Zoltan Foundation for Applied Research at Semmelweis University, Budapest, joins Helen Winsor Pharma IQ, to discuss developments in immunogenicity. In this exclusive interview, Szebeni talks about the aims of his current research and how this will affect our current understanding of immunogenicity. He outlines the main challenges faced and the best practice methods that have been put in place to overcome these...
To continue reading this story
Please note: That all fields marked with an asterisk (*) are required.